BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1714669)

  • 1. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
    Assmann I; Kassel P; von Knorre G
    Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of bonnecor in the treatment of ventricular arrhythmia].
    Fomichev VI; Smerdina IS; Preobrazhenskiĭ DV; Gorshkov VA
    Klin Med (Mosk); 1995; 73(4):44-6. PubMed ID: 7474818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
    Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the effectiveness of Bonnecor and ethacizine in various disorders of cardiac rhythm].
    Tatarchenko IP; Ermolaeva NN; Oleĭnikov VE; Perevarin AV; Rakhmatullov FK
    Klin Med (Mosk); 1991 Aug; 69(8):60-2. PubMed ID: 1724273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic effect and kinetic parameters of bonnecor in the treatment of extrasystole in patients with acute myocardial infarction].
    Ol'binskaia LI; Sizova ZhM; Tiukavkina NA; Beloborodov VL; Kosilova EE; Kobeleva TA
    Kardiologiia; 1990 Dec; 30(12):9-11. PubMed ID: 1711135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
    Korsukewitz J; Wegscheider K; Schmutzler H
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1103-7. PubMed ID: 2408842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug prevention and therapy of ventricular tachycardia].
    Burckhardt D; Hoffmann A
    Ther Umsch; 1992 Aug; 49(8):543-9. PubMed ID: 1519183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
    Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
    Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor based on the data from an acute drug test].
    Smerdina IS; Fomichev VI; Nesvetov VN; Gorshkov VA; Preobrazhenskiĭ DV
    Kardiologiia; 1993; 33(7):11-4, 3. PubMed ID: 8309173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of stress-induced therapy refractory ventricular tachycardia with verapamil].
    Kühlkamp V; Kohler S; Seipel L
    Z Kardiol; 1989 Jun; 78(6):405-7. PubMed ID: 2474223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.